Syncell
Taipei, Taiwan· Est.
Syncell delivers a microscopy‑guided spatial proteomics platform for unbiased subcellular protein discovery in cancer and immune research.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Syncell delivers a microscopy‑guided spatial proteomics platform for unbiased subcellular protein discovery in cancer and immune research.
OncologyImmunologyNeuroscience
Technology Platform
Microscoop® combines microscopy‑guided photochemical labeling, micro‑dissection, and high‑resolution mass spectrometry to enable unbiased subcellular proteomic profiling.
Opportunities
Rapid adoption of spatial omics in pharma R&D and the ability to integrate with multi‑omics pipelines present strong growth potential.
Risk Factors
Market adoption hinges on demonstrating reproducibility, scaling manufacturing, and competing against well‑funded incumbents such as 10x Genomics.
Competitive Landscape
Key competitors include 10x Genomics, NanoString, and Bruker; Syncell differentiates through its microscopy‑guided protein purification workflow that offers higher spatial specificity and unbiased proteome coverage.